Ang B S, Telenti A, King B, Steckelberg J M, Wilson W R
Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Clin Infect Dis. 1993 Oct;17(4):662-6. doi: 10.1093/clinids/17.4.662.
Twenty-six cases of candidemia associated with a well-defined urinary tract source were retrospectively identified and reviewed. Urinary tract abnormalities were present in 23 of 26 patients (88%), 19 (73%) of whom had urinary tract obstruction. Nineteen patients had undergone urinary tract procedures before the onset of candidemia. Episodes of candidemia were brief and low-grade in intensity (median duration, 1 day; median colony count, 1.5 cfu/10 mL of blood). Only eight patients (31%) received > or = 500 mg of amphotericin B. There were five in-hospital deaths (19%); two of these deaths were attributed to candidiasis. No late complications of candidemia were documented for the surviving patients. Patients with urologic pathology and candiduria who undergo surgery or manipulation of the urinary tract are at significant risk for candidemia, and further studies should examine the issue of administration of prophylaxis to this group.
回顾性鉴定并分析了26例明确由泌尿道感染源引起的念珠菌血症病例。26例患者中有23例(88%)存在泌尿道异常,其中19例(73%)有泌尿道梗阻。19例患者在念珠菌血症发作前接受过泌尿道手术。念珠菌血症发作时间短,程度轻(中位持续时间1天;中位菌落计数为每10毫升血液1.5 cfu)。只有8例患者(31%)接受了≥500毫克的两性霉素B治疗。住院期间有5例死亡(19%);其中2例死亡归因于念珠菌病。存活患者未记录到念珠菌血症的晚期并发症。患有泌尿系统病理疾病和念珠菌尿症且接受泌尿道手术或操作的患者发生念珠菌血症的风险很高,进一步的研究应探讨对该群体进行预防性给药的问题。